Filed: 11/14/2023ACC: 0001172661-23-004025
📋 What this filing means
GREAT POINT PARTNERS LLC filed this quarterly 13F‑HR report disclosing 40 equity positions with a total reported market value of $549.04M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
40
Positions
$549.04M
Total AUM (reported)
55.79M
Total Shares
Allocation by class
COM$445.79M81.2%
SHS$24.51M4.5%
CLASS A ORD SHS$21.75M4.0%
COM NEW$18.81M3.4%
ADS$15.10M2.8%
COMMON STOCK$10.32M1.9%
COM PAR $.01$9.97M1.8%
Portfolio Concentration
Top 3$103.51M18.9%
4–10$173.93M31.7%
11–25$202.25M36.8%
Rest$69.36M12.6%
Top 3 weight
18.9%
Top 10 weight
50.5%
Voting Authority Distribution
Total shares with voting rights: 55.79M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
55.79M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other40
Dominant voting typeShared · 100.0% of voting shares
Institutional Holdings40
Rows:
UROGEN PHARMA LTD
DFNDShares2.62M
TypeSH
Market value$36.71M
6.69%
Sole
0.00
Shared
2.62M
None
0.00
ALPINE IMMUNE SCIENCES INC
DFNDShares3.08M
TypeSH
Market value$35.25M
6.42%
Sole
0.00
Shared
3.08M
None
0.00
SAREPTA THERAPEUTICS INC
DFNDShares260.20K
TypeSH
Market value$31.54M
5.74%
Sole
0.00
Shared
260.20K
None
0.00
PLIANT THERAPEUTICS INC
DFNDShares1.76M
TypeSH
Market value$30.43M
5.54%
Sole
0.00
Shared
1.76M
None
0.00
VAXCYTE INC
DFNDShares531.21K
TypeSH
Market value$27.08M
4.93%
Sole
0.00
Shared
531.21K
None
0.00
ULTRAGENYX PHARMACEUTICAL IN
DFNDShares727.43K
TypeSH
Market value$25.93M
4.72%
Sole
0.00
Shared
727.43K
None
0.00
ALKERMES PLC
DFNDShares875.04K
TypeSH
Market value$24.51M
4.46%
Sole
0.00
Shared
875.04K
None
0.00
RAPT THERAPEUTICS INC
DFNDShares1.46M
TypeSH
Market value$24.23M
4.41%
Sole
0.00
Shared
1.46M
None
0.00
ZURA BIO LTD
DFNDShares3.29M
TypeSH
Market value$21.75M
3.96%
Sole
0.00
Shared
3.29M
None
0.00
EVOLUS INC
DFNDShares2.19M
TypeSH
Market value$19.99M
3.64%
Sole
0.00
Shared
2.19M
None
0.00
POINT BIOPHARMA GLOBAL INC
DFNDShares2.91M
TypeSH
Market value$19.41M
3.54%
Sole
0.00
Shared
2.91M
None
0.00
CYTOKINETICS INC
DFNDShares600K
TypeSH
Market value$17.68M
3.22%
Sole
0.00
Shared
600K
None
0.00
XENON PHARMACEUTICALS INC
DFNDShares500K
TypeSH
Market value$17.08M
3.11%
Sole
0.00
Shared
500K
None
0.00
ACLARIS THERAPEUTICS INC
DFNDShares2.39M
TypeSH
Market value$16.38M
2.98%
Sole
0.00
Shared
2.39M
None
0.00
ANAPTYSBIO INC
DFNDShares894.33K
TypeSH
Market value$16.06M
2.93%
Sole
0.00
Shared
894.33K
None
0.00
IMMUNOCORE HLDGS PLC
DFNDShares290.92K
TypeSH
Market value$15.10M
2.75%
Sole
0.00
Shared
290.92K
None
0.00
AEROVATE THERAPEUTICS INC
DFNDShares1.09M
TypeSH
Market value$14.81M
2.70%
Sole
0.00
Shared
1.09M
None
0.00
INTRA-CELLULAR THERAPIES INC
DFNDShares225K
TypeSH
Market value$11.72M
2.13%
Sole
0.00
Shared
225K
None
0.00
PTC THERAPEUTICS INC
DFNDShares500K
TypeSH
Market value$11.21M
2.04%
Sole
0.00
Shared
500K
None
0.00
REPLIMUNE GROUP INC
DFNDShares638.50K
TypeSH
Market value$10.92M
1.99%
Sole
0.00
Shared
638.50K
None
0.00
OPTINOSE INC
DFNDShares8.84M
TypeSH
Market value$10.87M
1.98%
Sole
0.00
Shared
8.84M
None
0.00
AMICUS THERAPEUTICS INC
DFNDShares857K
TypeSH
Market value$10.42M
1.90%
Sole
0.00
Shared
857K
None
0.00
ARCELLX INC
DFNDShares287.50K
TypeSH
Market value$10.32M
1.88%
Sole
0.00
Shared
287.50K
None
0.00
KARUNA THERAPEUTICS INC
DFNDShares60.50K
TypeSH
Market value$10.23M
1.86%
Sole
0.00
Shared
60.50K
None
0.00
AKERO THERAPEUTICS INC
DFNDShares198.50K
TypeSH
Market value$10.04M
1.83%
Sole
0.00
Shared
198.50K
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
UROGEN PHARMA LTDDFND | COM | 2.62M | SH | $36.71M 6.69% | 0.00 | 2.62M | 0.00 |
ALPINE IMMUNE SCIENCES INCDFND | COM | 3.08M | SH | $35.25M 6.42% | 0.00 | 3.08M | 0.00 |
SAREPTA THERAPEUTICS INCDFND | COM | 260.20K | SH | $31.54M 5.74% | 0.00 | 260.20K | 0.00 |
PLIANT THERAPEUTICS INCDFND | COM | 1.76M | SH | $30.43M 5.54% | 0.00 | 1.76M | 0.00 |
VAXCYTE INCDFND | COM | 531.21K | SH | $27.08M 4.93% | 0.00 | 531.21K | 0.00 |
ULTRAGENYX PHARMACEUTICAL INDFND | COM | 727.43K | SH | $25.93M 4.72% | 0.00 | 727.43K | 0.00 |
ALKERMES PLCDFND | SHS | 875.04K | SH | $24.51M 4.46% | 0.00 | 875.04K | 0.00 |
RAPT THERAPEUTICS INCDFND | COM | 1.46M | SH | $24.23M 4.41% | 0.00 | 1.46M | 0.00 |
ZURA BIO LTDDFND | CLASS A ORD SHS | 3.29M | SH | $21.75M 3.96% | 0.00 | 3.29M | 0.00 |
EVOLUS INCDFND | COM | 2.19M | SH | $19.99M 3.64% | 0.00 | 2.19M | 0.00 |
POINT BIOPHARMA GLOBAL INCDFND | COM | 2.91M | SH | $19.41M 3.54% | 0.00 | 2.91M | 0.00 |
CYTOKINETICS INCDFND | COM NEW | 600K | SH | $17.68M 3.22% | 0.00 | 600K | 0.00 |
XENON PHARMACEUTICALS INCDFND | COM | 500K | SH | $17.08M 3.11% | 0.00 | 500K | 0.00 |
ACLARIS THERAPEUTICS INCDFND | COM | 2.39M | SH | $16.38M 2.98% | 0.00 | 2.39M | 0.00 |
ANAPTYSBIO INCDFND | COM | 894.33K | SH | $16.06M 2.93% | 0.00 | 894.33K | 0.00 |
IMMUNOCORE HLDGS PLCDFND | ADS | 290.92K | SH | $15.10M 2.75% | 0.00 | 290.92K | 0.00 |
AEROVATE THERAPEUTICS INCDFND | COM | 1.09M | SH | $14.81M 2.70% | 0.00 | 1.09M | 0.00 |
INTRA-CELLULAR THERAPIES INCDFND | COM | 225K | SH | $11.72M 2.13% | 0.00 | 225K | 0.00 |
PTC THERAPEUTICS INCDFND | COM | 500K | SH | $11.21M 2.04% | 0.00 | 500K | 0.00 |
REPLIMUNE GROUP INCDFND | COM | 638.50K | SH | $10.92M 1.99% | 0.00 | 638.50K | 0.00 |
OPTINOSE INCDFND | COM | 8.84M | SH | $10.87M 1.98% | 0.00 | 8.84M | 0.00 |
AMICUS THERAPEUTICS INCDFND | COM | 857K | SH | $10.42M 1.90% | 0.00 | 857K | 0.00 |
ARCELLX INCDFND | COMMON STOCK | 287.50K | SH | $10.32M 1.88% | 0.00 | 287.50K | 0.00 |
KARUNA THERAPEUTICS INCDFND | COM | 60.50K | SH | $10.23M 1.86% | 0.00 | 60.50K | 0.00 |
AKERO THERAPEUTICS INCDFND | COM | 198.50K | SH | $10.04M 1.83% | 0.00 | 198.50K | 0.00 |
Page 1 of 2